Turnstone Biologics

United States
San Diego, California, United States, 92037

Company profile

Turnstone Biologics company profile

Turnstone Biologics is a privately-held clinical-stage biotech company. Turnstone Biologics’ mission is to deliver breakthrough cancer immunotherapies by advancing two leading and complementary platforms targeting tumor immunity, to improve survival for people with cancer.

Business identity

Contact email
[email protected]
Phone number
(613)421-8930
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2015-01-01, Year

Headquarters

Postal code
92037
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
5
Total equity funding
$132.7M
Last funding
Series D / $80M / 2021-07-14
Last equity funding
Series D / $80M
Investors
20
Lead investors
5
Founders
3
Articles
68
Exited on
2023-07-21

Founders and investors

Founders

Brian LichtyDavid StojdlJohn Bell

Lead investors

OrbiMedPFM Health SciencesPoint72TakedaVersant Ventures

Investors

Eight Roads VenturesF-PrimeNorthleaf Capital PartnersOrbiMedPoint72